The researchers also noted that some suicides might have been misclassified in the official records they used
If we recall that approximately 25% of total weight loss in persons with obesity is accounted for by FFM, the authors found that fat free mass accounted for 33%, 39%, and 25% of total weight loss for retatrutide ( Phase 2 data only, not yet FDA approved), semaglutide and tirzepatide respectively whereas fat mass loss accounted for 67%, 61%, and 75% respectively
There is limited information on Tirzepatide use during pregnancy or breastfeeding
Common Symptoms: Hyperthyroidism symptoms Excessive sweating Rapid heart rate Difficulty regulating blood sugar levels No symptoms (most commonly) Thyroid pain (few cases) Preventing Thyroid Nodule Patients should be comforted knowing that up to half of all people have at least one thyroid nodule, and most of these are harmless and caused by non-dangerous conditions
Semaglutide changed my life, and I will be forever grateful
Patients should be educated to recognize: Dizziness and confusion Palpitations Excessive sweating 13.5 Lifestyle Integration (Diet and Exercise) Pharmacotherapy should complement lifestyle modifications